Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06657612
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-22
Brief Title:
Is Ultrasound-Guided Steroid Injection Less Effective in Carpal Tunnel Syndrome Patients With Bifid Median Nerve
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Is Ultrasound-Guided Steroid Injection Less Effective in Carpal Tunnel Syndrome Patients With Bifid Median Nerve A Focus on Short-Term Efficacy
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to evaluate the short-term efficacy of ultrasound-guided corticosteroid injection in patients with and without bifid median nerve
Detailed Description:
Twenty-five patients with bifid median nerve and twenty-five patients without bifid median nerve aged 18-65 who applied to the Physical Therapy and Rehabilitation outpatient clinic at Beylikdüzü State Hospital diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological studies and who received ultrasound-guided corticosteroid injection will be included in our study Patients identified as having a bifid median nerve during the injection will be noted and invited for a follow-up at the 1st month to assess their pain and functional status The same follow-up visit will be conducted for an equal number of age- and gender-matched patients without bifid median nerve who received the injection At the end of the study the 1-month efficacy of the injection in both groups will be evaluated Patients who agree to participate in the study will be asked to complete the Visual Analog Scale VAS the Boston Carpal Tunnel Syndrome Questionnaire BCTQ and the Quick Disabilities of the Arm Shoulder and Hand Questionnaire Quick-DASH before the injection They will then be invited for a follow-up visit at the 1st month where the VAS BCTQ and Quick-DASH will be administered again
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None